Health Ebitda from 2010 to 2024

HCAT Stock  USD 7.03  0.25  3.69%   
Health Catalyst EBITDA yearly trend continues to be comparatively stable with very little volatility. EBITDA will likely drop to about -42.6 M in 2024. From the period from 2010 to 2024, Health Catalyst EBITDA quarterly data regression had mean square error of 379.2 T and mean deviation of  16,151,404. View All Fundamentals
 
EBITDA  
First Reported
2018-03-31
Previous Quarter
-10.4 M
Current Value
-6 M
Quarterly Volatility
8.3 M
 
Covid
Check Health Catalyst financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Health main balance sheet or income statement drivers, such as Tax Provision of 373.8 K, Net Interest Income of 9.6 M or Interest Income of 17.2 M, as well as many exotic indicators such as Price To Sales Ratio of 1.68, Dividend Yield of 0.0 or PTB Ratio of 1.0. Health financial statements analysis is a perfect complement when working with Health Catalyst Valuation or Volatility modules.
  
This module can also supplement Health Catalyst's financial leverage analysis and stock options assessment as well as various Health Catalyst Technical models . Check out the analysis of Health Catalyst Correlation against competitors.
For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.

Latest Health Catalyst's Ebitda Growth Pattern

Below is the plot of the Ebitda of Health Catalyst over the last few years. It is Health Catalyst's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Health Catalyst's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Health Ebitda Regression Statistics

Arithmetic Mean(51,553,617)
Coefficient Of Variation(42.21)
Mean Deviation16,151,404
Median(39,648,000)
Standard Deviation21,760,155
Sample Variance473.5T
Range66.5M
R-Value(0.51)
Mean Square Error379.2T
R-Squared0.26
Significance0.05
Slope(2,463,521)
Total Sum of Squares6629.1T

Health Ebitda History

2024-42.6 M
2023-40.5 M
2022-91.7 M
2021-106.1 M
2020-77.4 M
2019-45.7 M
2018-52.1 M

About Health Catalyst Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Health Catalyst income statement, its balance sheet, and the statement of cash flows. Health Catalyst investors use historical funamental indicators, such as Health Catalyst's Ebitda, to determine how well the company is positioned to perform in the future. Although Health Catalyst investors may use each financial statement separately, they are all related. The changes in Health Catalyst's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Health Catalyst's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Health Catalyst Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Health Catalyst. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-40.5 M-42.6 M

Pair Trading with Health Catalyst

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Health Catalyst position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Catalyst will appreciate offsetting losses from the drop in the long position's value.

Moving together with Health Stock

  0.73DH Definitive HealthcarePairCorr
  0.83LH LaboratoryPairCorr

Moving against Health Stock

  0.55CI Cigna CorpPairCorr
  0.52DXCM DexCom IncPairCorr
  0.46EDAP EDAP TMS SAPairCorr
The ability to find closely correlated positions to Health Catalyst could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Health Catalyst when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Health Catalyst - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Health Catalyst to buy it.
The correlation of Health Catalyst is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Health Catalyst moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Health Catalyst moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Health Catalyst can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Health Catalyst is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Health Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Health Catalyst Stock. Highlighted below are key reports to facilitate an investment decision about Health Catalyst Stock:
Check out the analysis of Health Catalyst Correlation against competitors.
For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.
Note that the Health Catalyst information on this page should be used as a complementary analysis to other Health Catalyst's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Health Stock analysis

When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Health Catalyst's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Health Catalyst. If investors know Health will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Health Catalyst listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.84)
Revenue Per Share
5.189
Quarterly Revenue Growth
0.012
Return On Assets
(0.07)
Return On Equity
(0.28)
The market value of Health Catalyst is measured differently than its book value, which is the value of Health that is recorded on the company's balance sheet. Investors also form their own opinion of Health Catalyst's value that differs from its market value or its book value, called intrinsic value, which is Health Catalyst's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Health Catalyst's market value can be influenced by many factors that don't directly affect Health Catalyst's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Health Catalyst's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Catalyst is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health Catalyst's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.